For the BC subtypes that overexpress ER, molecular imaging using 16α-[18F]-fluoro-17β-estradiol ([18F]FES) has been recognized as a valuable tool to overcome clinical dilemmas, when distant metastasis cannot be safely reached for biopsies sampling or when ER heterogeneity is suspected between tumor lesions (39). The gene discussed is ESR1; the disease is breast cancer.